Trial intelligence / Profile preview

Phase II open-label dasatinib trial in systemic mastocytosis

2008-006183-11Phase 2Active

Sponsor

University of Naples Federico II

Start

Oct 2009

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1